Filing Details
- Accession Number:
- 0001722024-20-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-18 19:10:10
- Reporting Period:
- 2020-09-18
- Accepted Time:
- 2020-09-18 19:10:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1634379 | Metacrine Inc. | MTCR | Pharmaceutical Preparations (2834) | 472297384 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1722024 | Alexandria Venture Investments, Llc | 26 North Euclid Avenue Pasadena CA 91101 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-18 | 1,268,795 | $0.00 | 1,268,795 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2020-09-18 | 38,461 | $13.00 | 1,307,256 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A convertible preferred stock | Disposition | 2020-09-18 | 4,599,997 | $0.00 | 901,960 | $0.00 |
| Common Stock | Series B convertible preferred stock | Disposition | 2020-09-18 | 1,107,899 | $0.00 | 217,235 | $0.00 |
| Common Stock | Series C convertible preferred stock | Disposition | 2020-09-18 | 762,961 | $0.00 | 149,600 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 5.1 shares of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on September 18, 2020, for no additional consideration. The shares had no expiration date.
- Not applicable.
Billionaire Hedge Funds
